{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:56:12Z","timestamp":1760550972809,"version":"3.37.3"},"reference-count":18,"publisher":"The Endocrine Society","issue":"4","license":[{"start":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T00:00:00Z","timestamp":1572220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,4,1]]},"DOI":"10.1210\/clinem\/dgz132","type":"journal-article","created":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T17:37:17Z","timestamp":1572457037000},"page":"e1897-e1900","source":"Crossref","is-referenced-by-count":5,"title":["Is Chemotherapy Implicated in the Development of Hypopituitarism in Childhood Cancer Survivors?"],"prefix":"10.1210","volume":"105","author":[{"given":"Khyatisha","family":"Seejore","sequence":"first","affiliation":[{"name":"Leeds Centre for Diabetes and Endocrinology, Department of Endocrinology, Leeds Teaching Hospitals NHS Trust, Leeds, UK"},{"name":"Leeds Institute for Cardiovascular and Metabolic Medicine (LICAMM), University of Leeds, Leeds, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Kyriakakis","sequence":"additional","affiliation":[{"name":"Leeds Centre for Diabetes and Endocrinology, Department of Endocrinology, Leeds Teaching Hospitals NHS Trust, Leeds, UK"},{"name":"Leeds Institute for Cardiovascular and Metabolic Medicine (LICAMM), University of Leeds, Leeds, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6730-6109","authenticated-orcid":false,"given":"Robert D","family":"Murray","sequence":"additional","affiliation":[{"name":"Leeds Centre for Diabetes and Endocrinology, Department of Endocrinology, Leeds Teaching Hospitals NHS Trust, Leeds, UK"},{"name":"Leeds Institute for Cardiovascular and Metabolic Medicine (LICAMM), University of Leeds, Leeds, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2019,10,28]]},"reference":[{"issue":"1","key":"2021122209575153400_CIT0001","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nrc3634","article-title":"Survivors of childhood and adolescent cancer: life-long risks and responsibilities","volume":"14","author":"Robison","year":"2014","journal-title":"Nat Rev Cancer."},{"issue":"36","key":"2021122209575153400_CIT0002","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.1200\/JCO.2016.67.5025","article-title":"Prevalence and risk factors of early endocrine disorders in childhood brain tumor survivors: a nationwide, multicenter study","volume":"34","author":"Clement","year":"2016","journal-title":"J Clin Oncol."},{"issue":"12","key":"2021122209575153400_CIT0003","doi-asserted-by":"crossref","first-page":"6101","DOI":"10.1210\/jc.2019-00834","article-title":"Hypothalamic-pituitary disorders in childhood cancer survivors: prevalence, risk factors and long-term health outcomes","volume":"104","author":"van Iersel","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"issue":"7","key":"2021122209575153400_CIT0004","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/1097-0142(19860401)57:7<1287::AID-CNCR2820570706>3.0.CO;2-O","article-title":"Hypothalamic-pituitary function of children with acute lymphocytic leukemia after three forms of central nervous system prophylaxis. A retrospective study","volume":"57","author":"Voorhess","year":"1986","journal-title":"Cancer."},{"issue":"6","key":"2021122209575153400_CIT0005","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/(SICI)1096-911X(199806)30:6<351::AID-MPO9>3.0.CO;2-D","article-title":"Growth and endocrinological disorders up to 21 years after treatment for acute lymphoblastic leukemia in childhood","volume":"30","author":"Birkebaek","year":"1998","journal-title":"Med Pediatr Oncol."},{"issue":"2","key":"2021122209575153400_CIT0006","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/mpo.2950250208","article-title":"Chemotherapy-induced growth hormone deficiency in children with cancer","volume":"25","author":"Rom\u00e1n","year":"1995","journal-title":"Med Pediatr Oncol."},{"issue":"1","key":"2021122209575153400_CIT0007","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1515\/JPEM.2004.17.1.55","article-title":"Hypothalamic dysfunction after chemotherapy","volume":"17","author":"Rose","year":"2004","journal-title":"J Pediatr Endocrinol Metab."},{"issue":"2","key":"2021122209575153400_CIT0008","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/pbc.20485","article-title":"Growth hormone deficiency after chemotherapy for acute lymphoblastic leukemia in children who have not received cranial radiation","volume":"46","author":"Haddy","year":"2006","journal-title":"Pediatr Blood Cancer."},{"issue":"13","key":"2021122209575153400_CIT0009","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1200\/JCO.2002.09.142","article-title":"Outcomes of growth hormone replacement therapy in survivors of childhood acute lymphoblastic leukemia","volume":"20","author":"Leung","year":"2002","journal-title":"J Clin Oncol."},{"issue":"1","key":"2021122209575153400_CIT0010","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/BF01972968","article-title":"Prolonged intrathecal chemotherapy replacing cranial irradiation in high-risk acute lymphatic leukaemia: long-term follow up with cerebral computed tomography scans and endocrinological studies","volume":"154","author":"Hasle","year":"1995","journal-title":"Eur J Pediatr."},{"issue":"12","key":"2021122209575153400_CIT0011","doi-asserted-by":"crossref","first-page":"6490","DOI":"10.1210\/jc.2005-1593","article-title":"Circadian and stimulated thyrotropin secretion in cranially irradiated adult cancer survivors","volume":"90","author":"Darzy","year":"2005","journal-title":"J Clin Endocrinol Metab."},{"issue":"8","key":"2021122209575153400_CIT0012","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1210\/jc.2018-01175","article-title":"Hypothalamic-pituitary and growth disorders in survivors of childhood cancer: an Endocrine Society clinical practice guideline","volume":"103","author":"Sklar","year":"2018","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2021122209575153400_CIT0013","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1046\/j.1365-2265.1996.00855.x","article-title":"The assessment of growth hormone status in normal young adult males using a variety of provocative agents","volume":"45","author":"Rahim","year":"1996","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"9","key":"2021122209575153400_CIT0014","first-page":"3323","article-title":"Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children","volume":"81","author":"Ghigo","year":"1996","journal-title":"J Clin Endocrinol Metab."},{"issue":"8","key":"2021122209575153400_CIT0015","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1210\/jc.2018-01204","article-title":"Diagnosis of GH deficiency as a late effect of radiotherapy in survivors of childhood cancers","volume":"103","author":"Sfeir","year":"2018","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2021122209575153400_CIT0016","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1530\/eje.1.01829","article-title":"Consensus statement on the management of the GH-treated adolescent in the transition to adult care","volume":"152","author":"Clayton","year":"2005","journal-title":"Eur J Endocrinol."},{"issue":"6","key":"2021122209575153400_CIT0017","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1530\/EJE-07-0631","article-title":"Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia","volume":"157","author":"Ho","year":"2007","journal-title":"Eur J Endocrinol."},{"issue":"2","key":"2021122209575153400_CIT0018","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1210\/jc.2003-031224","article-title":"Reassessment of growth hormone status is required at final height in children treated with growth hormone replacement after radiation therapy","volume":"89","author":"Gleeson","year":"2004","journal-title":"J Clin Endocrinol Metab."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgz132\/30316607\/dgz132.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/105\/4\/e1897\/41860028\/jcem_105_4_e1897.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/105\/4\/e1897\/41860028\/jcem_105_4_e1897.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T18:03:05Z","timestamp":1640196185000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/105\/4\/e1897\/5607976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,28]]},"references-count":18,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,10,28]]},"published-print":{"date-parts":[[2020,4,1]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgz132","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"type":"print","value":"0021-972X"},{"type":"electronic","value":"1945-7197"}],"subject":[],"published-other":{"date-parts":[[2020,4]]},"published":{"date-parts":[[2019,10,28]]}}}